Chronic conditions resources

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for MPS VI.

Treating physicians use this application form to apply for a patient to access LSDP medication for Fabry disease for the first time, or after a break.

This fact sheet is designed to help facilitate discussions between thalidomide survivors and their health care practitioners.

This fact sheet tells you about health care plans for chronic health problems. Chronic means something lasts a long time. Chronic health problems last a long time. You can download the fact sheet in PDF to read online or print.

This PNH review considered eculizumab. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

This PNH review considered eculizumab. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

This HT1 review considered nitisinone (only the brand Orfadin® was in scope for the review). The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

This HT1 review considered nitisinone (only the brand Orfadin® was in scope for the review). The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations in plain English for health consumers.

Use this form to help transition a patient’s care to a new physician, where there are no other changes to their treatment or eligibility for the Life Saving Drugs Program (LDSP).